# Clinical research progress on classic myeloproliferative neoplasms with hypertension

**Authors:** 文豪 张, 古生 唐

PMC · DOI: 10.3760/cma.j.cn121090-20240811-00300 · Chinese Journal of Hematology · 2025-06-01

## TL;DR

This paper reviews the clinical relationship between myeloproliferative neoplasms and hypertension to guide personalized treatment.

## Contribution

It provides a comprehensive overview of hypertension's impact on MPN patients, emphasizing its underappreciated clinical significance.

## Key findings

- Hypertension is the most common comorbidity in MPN patients.
- Hypertension significantly affects MPN clinical presentation and prognosis.
- Individualized treatment approaches are needed for MPN patients with hypertension.

## Abstract

慢性骨髓增殖性肿瘤（MPN）是一类以造血干细胞克隆性增生为特征的获得性恶性肿瘤，其中真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化被称为经典型费城染色体阴性的MPN。高血压是MPN患者最常见的伴发疾病，对MPN的临床表现、病情进展、治疗及预后有显著影响，但在临床工作中可能并未引起足够重视。本文对MPN伴高血压的流行病学及临床问题进行综述，以协助临床医师对该类患者进行个体化治疗。

## Linked entities

- **Diseases:** myeloproliferative neoplasms (MONDO:0020076), primary myelofibrosis (MONDO:0009692), essential thrombocythemia (MONDO:0005029), polycythemia vera (MONDO:0009891)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12337220/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12337220/full.md

---
Source: https://tomesphere.com/paper/PMC12337220